AI-Based ‘Liquid Biopsies’ Using Cell-Free DNA and Protein Biomarkers Could Aid Early Detection of Ovarian Cancer Technologies
Techstars, Johns Hopkins University, and CareFirst BlueCross BlueShield to Bring Healthcare A.I. Accelerator to Baltimore Collaborations
Precision Drug Olaparib May Be Effective Without Hormone Therapy for Some Men with Biochemically Recurrent Prostate Cancer Technologies
